- €71.69m
- €91.00m
- €90.55m
- 52
- 45
- 16
- 28
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 56.5 | 66.3 | 70.7 | 78.8 | 90.6 |
Cost of Revenue | |||||
Gross Profit | 27.9 | 36.1 | 38.9 | 49 | 54.4 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 55.2 | 61.6 | 69.5 | 77.7 | 90.7 |
Operating Profit | 1.32 | 4.73 | 1.19 | 1.1 | -0.158 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.77 | 4.53 | -0.189 | 1.62 | -0.391 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.71 | 4.61 | -0.275 | 1.78 | -0.046 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1.71 | 4.61 | -0.275 | 1.14 | -0.046 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.71 | 4.61 | -0.275 | 1.14 | -0.046 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.16 | 0.43 | -0.026 | 0.16 | -0.004 |
Dividends per Share |